ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2019 first-quarter conference call on Tuesday, October 30, 2019, at 3:45 p.m. CT (4:45 p.m. ET). CSI management will discuss results for its fiscal first quarter ended September 30, 2018, and its financial outlook. The company will issue a post-market earnings release prior to the call on October 30, 2018.
To access the live webcast, go to the events section of the company’s investor relations website, http://investors.csi360.com/Investors/Events, on the day of the conference, call and click on the webcast link. A webcast replay will be available beginning at 6:45 p.m. CT the same day.
To participate in the conference call, dial (833) 241-7255 and enter 8761896. Please dial in at least 10 minutes prior to the call.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. The Stealth 360® Peripheral Orbital Atherectomy System (OAS) received CE Mark in October 2014. As of June 30, 2018, over 392,000 of CSI’s devices have been sold to leading institutions across the United States and Japan.